Minneapolis Clinical Trials
2019 Study (Healthy) (MAD)
The purpose of Study 2019 is to evaluate the safety and tolerability of BIO 300 for multiple clinical indications related to DNA damage and inflammation
0 nights
10 visits
During Study 2019, participants will receive the investigative treatment via dry powder dissolved in water, which must then be swallowed.
There is one screening appointment, eight clinic visits for treatment and a single follow-up appointment. Compensation for study participation may be provided for time and travel up to $1725.
This study has been approved by an independent ethics committee.
Call Gigi at 651-724-7832 or email her at jilank@nucleusnetwork.com to discuss your eligibility today!
Eligibility
Biological Sex Healthy males or females
Age 18 - 64 years old
BMI 18 - 32
Medication Not taking any (hormonal birth control is allowed)
Smoking History Non-smokers